diseases - International Biopharmaceutical Industry

Current Edition

news

AbbVie keeps up dealmaking pace in neuroscience

Dive Brief: AbbVie announced Friday a new agreement with its longtime partner Gedeon Richter to research and develop dopamine-regulating treatments for neuropsychi...

14 March 2022 news ABBVIE | dealmaking

Continue Reading →

news

Star Therapeutics emerges with plans to treat rare diseases through a solar system of drug companies

Few things are as human as gazing into the night sky. And yet, after thousands of years, we know only a little about what we're looking at and how it all works. Spac...

18 February 2022 news diseases | rare

Continue Reading →

news

The pipeline of new antibiotics is drying up. A bill in Congress aims to change that

Bacteria that can defeat current antibiotic drugs are sometimes called "the next pandemic." Already, infections from them are believed to cause or contribute to more ...

6 February 2022 news antibiotics | diseases

Continue Reading →

news

Gene Therapies That Could Transform Diseases Get Easier FDA Path

New therapies that may cure diseases caused by defective genes will get a faster path to approval by U.S. regulators, part of an effort by the Food and Drug Administr...

25 May 2018 news diseases | easier

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

AbbVie keeps up dealmaking pace in neuroscience

Star Therapeutics emerges with plans to treat rare diseases through a solar system of drug companies

The pipeline of new antibiotics is drying up. A bill in Congress aims to change that

Gene Therapies That Could Transform Diseases Get Easier FDA Path

International Biopharmaceutical Industry